Biotecnología

Biotecnología

Desarrollan el primer organoide cardiaco con todas sus cámaras
29/11/2023 - Las cardiopatías matan al año en el mundo a cerca de 18 millones de personas,...
ACROBiosystems Launches GMP-grade DLL4 Protein
22/11/2023 - Aims to accelerate stem cell manufacturing.
Avid Partners with California Institute for Regenerative Medicine
09/11/2023 - CIRM-funded programs to receive access to Avid’s suite of world-class CGT CDMO services.
Pluristyx, ARMI | BioFab USA Commercialize Clinical-Grade Stem Cells
13/07/2023 - Agreement provides access to regulatory compliant iPSCs for ARMI members.
Be The Match BioTherapies to Support Garuda Therapeutics’ Cell Therapies
23/06/2023 - Partnership aims to provide broad access to consistent, durable, HLA-compatible and transgene-free blood stem cell therapies.
Applied StemCell, CIRM Partner on Resources for Regenerative Therapies
15/06/2023 - To provide access to clinical-grade iPSCs and gene editing technologies to accelerate development.
Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
08/06/2023 - Extensive panel of consented patient samples and iPSC technology designed to advance AD drug development and patient stratification.
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault
05/06/2023 - Global CDMO unifies quality content and training for greater visibility and agility.
Novartis Buys Avrobio Gene Therapy for $88 Million
05/06/2023 - Purchases stem cell gene therapy program for cystinosis.
CATTI Opens Cell and Gene Therapy Training Center of Excellence
17/05/2023 - Initially, the program will focus on human pluripotent stem cell banking, aseptic techniques, GMP optimized for CGT manufacturing.
BioCentriq, panCELLa to Study Stem Cell-Derived NK Cell Expansion Technology
11/05/2023 - Agreement evaluates induced pluripotent stem cell-derived feeder cells to improve NK manufacturing.
Plasticell, LambdaGen Partner to Develop Allogeneic Cancer Immunotherapies
05/05/2023 - LambdaGen to produce iPSC lines that enhance anti-tumor activity and Plasticell will use its combinatorial screening technology to develop optimal protocols.
Cellipont Receives Investment from OrbiMed for Commercial Manufacturing Facility
22/03/2023 - New facility in Texas will have capabilities for process and analytical development and manufacturing services for CAR-T, IPSC, MSC and cell therapies.
BioStem Technologies to Acquire Auxocell Labs Assets
08/03/2023 - Assets provide expertise and resources to enhance manufacturing capabilities for a wide range of regenerative medicine products.
Theragent Enters Stem Cell Bank Production Contract with Accelerated Biosciences
16/01/2023 - The CDMO will produce cGMP-grade master cell bank for Accelerated’s human Trophoblast Stem Cells.
Fujifilm Inks Cell Therapy Deal with Novo Nordisk
06/01/2023 - Fujifilm Cellular Dynamics licenses its iPSC platform for the development of iPSC-derived cell therapies.
Fujifilm Invests in PhenoVista Biosciences
16/12/2022 - Investment aims to accelerate Development of New High-Content Screening Assay ServicesUsing Differentiated iPSCs.
Avectas Expands Collaboration with CCRM and OmniaBio Inc.
30/11/2022 - Will enable the development of gene-edited induced pluripotent stem cells using Avectas' non-viral cell engineering platform, SOLUPORE.
Resolution Therapeutics and CCRM Enter Research Collaboration
15/11/2022 - Will develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies.
Predicting Stem Cell Activity to Ensure Safe and Effective Therapies
03/11/2022 - Predicting Stem Cell Activity to Ensure Safe and Effective Therapies
Cellusion, Minaris Enter LOI for Manufacturing Process for Cell Therapy
13/10/2022 - Will develop the manufacturing process of Cellusion’s leading program, CLS001, a novel regenerative medicine product for bullous keratopathy treatment.